United States Últimas notícias

Brookfield Business (NYSE:BBUC) announced an agreement to sell its global construction business, Multiplex, to Obayashi for a total of $650 million.

Merck (NYSE:MRK) announced today that the U.S. Food and Drug Administration (FDA) has expanded the indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) to include children and adolescents aged 2 through 17 years who are at increased risk for pneumococcal disease.

Pfizer (NYSE:PFE) announced today that its Chief Financial Officer, Dave Denton, will depart the company on August 15, 2026, to accept a new position within the consumer goods industry.

Kroger (NYSE: KR) reported total sales of $46.1 billion for the first quarter of 2026, marking an increase from the $45.1 billion recorded in the first quarter of 2025.

Accenture (NYSE:ACN) reported financial results for the third quarter of fiscal 2026 ended May 31, 2026, highlighting $18.7 billion in revenue and a 9% increase in diluted earnings per share to $3.80.

Resonac President and CEO Hidehito Takahashi speaks exclusively on AI demand with Bloomberg TV's Shery Ahn at the Bloomberg Look Ahead 2026 event in Tokyo.

PermRock Royalty Trust (NYSE:PRT) announced a monthly cash distribution of $370,879.54, or $0.030485 per Trust Unit, for its stakeholders.

Tower Semiconductor (NASDAQ:TSEM) announced that it has shipped more than five million coherent photonic integrated circuits to customers of its partner, Marvell Technology (NASDAQ:MRVL).

Global Net Lease (NYSE:GNL) announced the declaration of quarterly cash dividends for four classes of its outstanding preferred stock.

DTS, a VPG (NYSE:VPG) company, has officially released the SLICE6 AIR-TC, a data acquisition module designed specifically for advanced flight testing and harsh aerospace environments.

Traders piled into betting on interest-rate hikes as soon as next month after Federal Reserve Chairman Kevin Warsh clear the central bank won't tolerate high inflation. The hawkish message was driven home by the projections of individual Fed members. Bloomberg's Alister Bull reports.

Samsung Bioepis and Organon (NYSE:OGN) have announced an expansion of their long-standing partnership, granting Organon exclusive commercialization rights in Canada for PYZCHIVA® (ustekinumab), a biosimilar referencing the biologic STELARA®.